Peg interferon alfa-2b

DRUG3 trials

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Merck Sharp & Dohme LLC, Beijing Ditan Hospital

Conditions

Chronic Hepatitis bHematological NeoplasmsImmunotherapyNeoplasmsRecurrence

Phase 1

Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)

CompletedNCT03554005

Merck Sharp & Dohme LLCNeoplasms

Start: 1997-12-29End: 2001-03-16Updated: 2019-07-15

Phase 2

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

CompletedNCT02634294

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineHematological Neoplasms, Recurrence

Start: 2015-08-31End: 2021-12-31Updated: 2023-03-16

Unknown Phase

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

Enrolling by invitationNCT06777173

Beijing Ditan HospitalChronic Hepatitis b, Immunotherapy

Start: 2023-12-01End: 2026-11-01Target: 180Updated: 2025-01-15